Dr. David Edward Ost, MD

Dr. Ost practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Ost's NPI, 1174504120, was assigned on November 8, 2005. Dr. Ost graduated from Sidney Kimmel Medical College in 1990. Dr. Ost's New York license number on file is 203177.

Dr. Ost's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Ost's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ost practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Ost's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Ost is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Ost's licenses on file in 6 states: New York, Florida, Texas, Oklahoma, Indiana and Illinois.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), pleural effusion, pneumonia, pulmonary fibrosis and tobacco use among the conditions Dr. Ost treats.

CMS data shows 615 Medicare services from Dr. Ost across 16 procedure codes in 2024, for 310 Medicare patients. Medicare paid $45,867 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 310 Medicare patients who saw Dr. Ost in 2024. The largest group is 65 to 74, with 176 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ost's median patient age at 70, with 59% women.

In 2024, Dr. Ost wrote 49 Medicare Part D claims for 20 patients. 29% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $5,238 in total drug cost. In 2016, CMS named 22 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Ost for performance year 2024, reported as part of a group. Dr. Ost accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 157 papers to Dr. Ost, published from 2003 to 2025. 2020 was the busiest year, with 10. The most frequent topics are Lung Neoplasms, Bronchoscopy and Carcinoma, Non-Small-Cell Lung. Dr. Ost has published most often in Chest. Dr. Ost's most frequent co-authors are Horiana Bogdana Grosu, MD, Carlos A. Jimenez, MD and Roberto Fernando Casal, MD.

Dmand AI links Dr. Ost to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Pleural Effusion, Malignant, Pleural Effusion and Lung Neoplasms. M.D. Anderson Cancer Center sponsors the most, 4.

CMS Open Payments shows 87 general payments to Dr. Ost from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. C. R. Bard, Inc. & Subsidiaries paid the most, $29,319.

Dmand AI lists 1 award for Dr. Ost, most recently ACP Fellow in 2001.

Dr. Ost graduated from Sidney Kimmel Medical College in 1990. Dr. Ost is a member of ACCP, ACP and ATS.

Dr. Ost is in network with 4 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.